-+ 0.00%
-+ 0.00%
-+ 0.00%

VAXCYTE COMPLETES ENROLLMENT OF OPUS-1 AND OPUS-2 PHASE 3 TRIALS EVALUATING VAX-31 FOR THE PREVENTION OF INVASIVE PNEUMOCOCCAL DISEASE AND PNEUMONIA IN ADULTS

Reuters·03/23/2026 12:30:01

Please log in to view news